Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.

PloS one - 1 Jan 2019

Zhang Xinyu, Fu Xin, Li Tianyu, Yan Huimin

Abstract excerpt

BACKGROUND AND AIMS: Many studies have investigated the association between the level of myeloid derived suppressor cells (MDSCs) and clinical features and prognosis of hepatocellular carcinoma (HCC), but the results remain controversial. This systematic review and meta-analysis was conducted to summarize all available data and estimate the relationship. METHODS: A comprehensive literature review was carried out...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Liver Neoplasms

Share to Myeloid-Derived Suppressor Cells

Share to Neoplasm Recurrence, Local

Source

Open in PubMed Open full text

Identifiers

PMID: 31790437
DOI: 10.1371/journal.pone.0225327
PMCID: PMC6886785

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.PMID 31790437Read ↗

Development of a Myeloid-Derived Suppressor Cells-Related Genes Predictive Signature for Prognostic Survival and Immunotherapeutic Responses in Hepatocellular CarcinomaSemantic proximity Read ↗

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.Semantic proximity Read ↗

Cholangiocarcinoma presents a distinct myeloid-derived suppressor cell signature compared to other hepatobiliary cancersSemantic proximity Read ↗

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.Semantic proximity Read ↗

Identification and External Validation of a Prognostic Signature Based on Myeloid-Derived Suppressor Cell-Related lncRNAs for Hepatocellular CarcinomaSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Myeloid cell path to malignancy: insights into liver cancerSemantic proximity Read ↗

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and CancerSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Colorectal CancerSemantic proximity Read ↗

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.